|
|
|
PERSPECTIVE
1 Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 2 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| The first 100 words of the full text of this article appear below. |
The "cancer stem cell" hypothesis has emerged as the leading paradigm in how we view the origin and perpetuation of neoplastic-initiating cells in leukemia and solid tumors (for review, see Buzzeo et al. 2007
). Central to this model is the concept that only a rare subpopulation of cells in the malignant clone retains or acquires the ability to self-renew and proliferate to initiate and maintain the disease. Although hematopoietic stem cells (HSC) with inherent self-renewal properties are generally believed to be the initiating cells for malignant transformation in acute leukemias, it is now evident that the target stem cell
| The crucial role of Meis1 in MLL-induced leukemia |
|---|
| Meis1 is a potent collaborative gene in leukemia |
|---|
| On the road to uncovering the molecular mechanisms underlying Meis1 function |
|---|
| The role of Meis1 in normal hematopoiesis |
|---|
| Meis1: a force to be reckoned with |
|---|
| Meis1: a knockout punch for leukemia |
|---|
Related Article